title: Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinoma.
authors.forename: C-P
authors.initials: CP
authors.lastname: Liang
authors.forename: C-S
authors.initials: CS
authors.lastname: Yang
authors.forename: J-L
authors.initials: JL
authors.lastname: Shen
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Chen
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001557:Benzenesulfonates / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib